Safety and Immunogenicity of Two Doses of Oral Cholera Vaccine (Shanchol) in Subjects Aged 1 Year and Older in the Philippines

Trial Profile

Safety and Immunogenicity of Two Doses of Oral Cholera Vaccine (Shanchol) in Subjects Aged 1 Year and Older in the Philippines

Completed
Phase of Trial: Phase IV

Latest Information Update: 10 Sep 2015

At a glance

  • Drugs Cholera vaccine inactivated (Primary)
  • Indications Cholera
  • Focus Adverse reactions; Pharmacodynamics
  • Sponsors Sanofi
  • Most Recent Events

    • 10 Sep 2015 Status changed from active, no longer recruiting to completed.
    • 17 Mar 2015 Planned End Date changed from 1 Jun 2015 to 1 Aug 2015 as reported by ClinicalTrials.gov record.
    • 17 Mar 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top